Titre : Trouble de la personnalité multiple

Trouble de la personnalité multiple : Questions médicales fréquentes

Termes MeSH sélectionnés :

DNA Copy Number Variations
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Trouble de la personnalité multiple : Questions médicales les plus fréquentes", "headline": "Trouble de la personnalité multiple : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Trouble de la personnalité multiple : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-12", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Trouble de la personnalité multiple" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles dissociatifs", "url": "https://questionsmedicales.fr/mesh/D004213", "about": { "@type": "MedicalCondition", "name": "Troubles dissociatifs", "code": { "@type": "MedicalCode", "code": "D004213", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.300" } } }, "about": { "@type": "MedicalCondition", "name": "Trouble de la personnalité multiple", "alternateName": "Dissociative Identity Disorder", "code": { "@type": "MedicalCode", "code": "D009105", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Antje A T S Reinders", "url": "https://questionsmedicales.fr/author/Antje%20A%20T%20S%20Reinders", "affiliation": { "@type": "Organization", "name": "Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK." } }, { "@type": "Person", "name": "Eline M Vissia", "url": "https://questionsmedicales.fr/author/Eline%20M%20Vissia", "affiliation": { "@type": "Organization", "name": "Heelzorg, Centre for Psychotrauma, Zwolle, The Netherlands." } }, { "@type": "Person", "name": "Sima Chalavi", "url": "https://questionsmedicales.fr/author/Sima%20Chalavi", "affiliation": { "@type": "Organization", "name": "Movement Control and Neuroplasticity Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Bethany L Brand", "url": "https://questionsmedicales.fr/author/Bethany%20L%20Brand", "affiliation": { "@type": "Organization", "name": "Department of Psychology." } }, { "@type": "Person", "name": "Ellert R S Nijenhuis", "url": "https://questionsmedicales.fr/author/Ellert%20R%20S%20Nijenhuis", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Engineering, King's College London, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mapping recurrent mosaic copy number variation in human neurons.", "datePublished": "2024-05-17", "url": "https://questionsmedicales.fr/article/38760338", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-024-48392-0" } }, { "@type": "ScholarlyArticle", "name": "A pan-cancer landscape of pathogenic somatic copy number variations.", "datePublished": "2023-10-18", "url": "https://questionsmedicales.fr/article/37858853", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbi.2023.104529" } }, { "@type": "ScholarlyArticle", "name": "Copy number variations in SPAST and ATL1 are rare among Brazilians.", "datePublished": "2023-01-15", "url": "https://questionsmedicales.fr/article/36537231", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cge.14280" } }, { "@type": "ScholarlyArticle", "name": "Copy number variation alters local and global mutational tolerance.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37652668", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/gr.277625.122" } }, { "@type": "ScholarlyArticle", "name": "Contribution of copy number variations to the risk of severe eating disorders.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35611833", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/pcn.13430" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles dissociatifs", "item": "https://questionsmedicales.fr/mesh/D004213" }, { "@type": "ListItem", "position": 4, "name": "Trouble de la personnalité multiple", "item": "https://questionsmedicales.fr/mesh/D009105" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Trouble de la personnalité multiple - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Trouble de la personnalité multiple", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Trouble de la personnalité multiple", "description": "Comment diagnostique-t-on ce trouble ?\nQuels critères sont utilisés pour le diagnostic ?\nLes tests psychologiques sont-ils nécessaires ?\nLe diagnostic est-il souvent tardif ?\nQui peut poser le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Trouble de la personnalité multiple", "description": "Quels sont les symptômes principaux ?\nY a-t-il des symptômes physiques associés ?\nLes personnes peuvent-elles se souvenir de leurs identités ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes crises de dissociation sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Trouble de la personnalité multiple", "description": "Peut-on prévenir ce trouble ?\nLe soutien familial est-il important ?\nLes traumatismes peuvent-ils être évités ?\nLes programmes éducatifs aident-ils ?\nLa sensibilisation est-elle cruciale ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Trouble de la personnalité multiple", "description": "Quels traitements sont disponibles ?\nLes médicaments sont-ils efficaces ?\nLa thérapie de groupe est-elle bénéfique ?\nCombien de temps dure le traitement ?\nLa thérapie est-elle toujours nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Trouble de la personnalité multiple", "description": "Quelles complications peuvent survenir ?\nLe risque de suicide est-il élevé ?\nLes relations sociales sont-elles affectées ?\nY a-t-il un risque d'abus de substances ?\nLes complications psychologiques sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Trouble de la personnalité multiple", "description": "Quels sont les facteurs de risque principaux ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress chronique est-il un facteur ?\nLes événements traumatiques sont-ils déterminants ?\nLes troubles de l'attachement influencent-ils ?", "url": "https://questionsmedicales.fr/mesh/D009105?mesh_terms=DNA+Copy+Number+Variations&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on ce trouble ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique des symptômes et l'exclusion d'autres troubles." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la présence de deux identités et des lacunes de mémoire significatives." } }, { "@type": "Question", "name": "Les tests psychologiques sont-ils nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent aider à évaluer la dissociation et à exclure d'autres troubles mentaux." } }, { "@type": "Question", "name": "Le diagnostic est-il souvent tardif ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diagnostic peut être retardé en raison de la méconnaissance du trouble par les professionnels." } }, { "@type": "Question", "name": "Qui peut poser le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un psychiatre ou un psychologue formé peut poser le diagnostic après une évaluation approfondie." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des identités distinctes, des amnésies et des changements d'humeur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes physiques associés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes physiques peuvent apparaître, comme des douleurs ou des troubles somatiques." } }, { "@type": "Question", "name": "Les personnes peuvent-elles se souvenir de leurs identités ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, les individus ne se souviennent pas des actions de leurs autres identités." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Les crises de dissociation sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les crises de dissociation peuvent survenir en réponse à des stress émotionnels." } }, { "@type": "Question", "name": "Peut-on prévenir ce trouble ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention, mais un soutien psychologique précoce peut aider." } }, { "@type": "Question", "name": "Le soutien familial est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un soutien familial solide peut réduire le risque de développer des troubles dissociatifs." } }, { "@type": "Question", "name": "Les traumatismes peuvent-ils être évités ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes dans l'enfance peut réduire le risque de développer le trouble." } }, { "@type": "Question", "name": "Les programmes éducatifs aident-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes éducatifs sur la santé mentale peuvent sensibiliser et prévenir les troubles." } }, { "@type": "Question", "name": "La sensibilisation est-elle cruciale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la sensibilisation au trouble peut aider à réduire la stigmatisation et favoriser le traitement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitivo-comportementale et la thérapie par la parole." } }, { "@type": "Question", "name": "Les médicaments sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de médicaments spécifiques, mais des antidépresseurs peuvent aider." } }, { "@type": "Question", "name": "La thérapie de groupe est-elle bénéfique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie de groupe peut offrir un soutien, mais elle n'est pas toujours appropriée." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut durer des mois à des années, selon la gravité et la réponse au traitement." } }, { "@type": "Question", "name": "La thérapie est-elle toujours nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie est généralement recommandée pour gérer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles de l'humeur, des comportements suicidaires et des abus de substances." } }, { "@type": "Question", "name": "Le risque de suicide est-il élevé ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de ce trouble présentent un risque accru de comportements suicidaires." } }, { "@type": "Question", "name": "Les relations sociales sont-elles affectées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les relations peuvent être gravement affectées en raison des comportements imprévisibles." } }, { "@type": "Question", "name": "Y a-t-il un risque d'abus de substances ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes peuvent avoir un risque accru d'abus de substances comme mécanisme d'adaptation." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles tels que l'anxiété et la dépression sont souvent associés au trouble." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents de traumatismes, d'abus ou de négligence durant l'enfance." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de troubles mentaux peut augmenter le risque de développer le trouble." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer au développement de troubles dissociatifs." } }, { "@type": "Question", "name": "Les événements traumatiques sont-ils déterminants ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des événements traumatiques graves, surtout durant l'enfance, sont des facteurs clés." } }, { "@type": "Question", "name": "Les troubles de l'attachement influencent-ils ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'attachement peuvent augmenter le risque de développer ce trouble." } } ] } ] }

Sources (10000 au total)

A pan-cancer landscape of pathogenic somatic copy number variations.

Copy number variations (CNVs) play crucial roles in physiological and pathological processes, including cancer. However, the functional implications of somatic CNVs in tumor progression and evolution ... Starting from 7352 copy number profiles across 33 different cancer types, we infer the pathogenicity of each CNV and perform both intra- and inter-tumor analyses to predict the functional impact of di... Our analysis uncovered large heterogeneity among different tumors suggesting in many cases distinct genetic drivers of tumorigenesis. Recurrent genomic alterations frequently coincide with dysfunction... This study contributes to elucidate the functional impact of pathogenic CNVs in tumor progression and sheds light on their potential as prognostic markers in specific cancer types....

Contribution of copy number variations to the risk of severe eating disorders.

Eating disorders (EDs) are complex, multifactorial psychiatric conditions. Previous studies identified pathogenic copy number variations associated with NDDs (NDD-CNVs) in ED patients. However, no sta... Using array comparative genomic hybridization (aCGH), we conducted a high-resolution CNV analysis of 71 severe female ED patients and 1045 female controls. According to the American College of Medical... Of the samples analyzed with aCGH, 70 severe ED patients (98.6%) and 1036 controls (99.1%) passed our quality control filtering. We obtained 189 and 2539 rare CNVs from patients and controls, respecti... Our study provides the first preliminary evidence that NDD-CNVs may confer risk for severe EDs. The pathophysiology may involve synaptic dysfunction....

Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.

Circulating cell-free DNA (cfDNA) is a noninvasive substitute to liver biopsy for hepatocellular carcinoma (HCC) molecular profiling. This study aimed to use cfDNA to investigate copy number variation... Real-Time Polymerase Chain Reaction was used to determine the CNV and cfDNA integrity index in 100 HCC patients.... CNV gain in BCL9 and RPS6KB1 genes was detected in 14% and 24% of patients, respectively. Gain in CNV of BCL9 associated with risk of HCC in alcohol drinkers and hepatitis C seropositivity. In patient... cfDNA was used to detect BCL9 and RPS6KB1 CNVs, which influence prognosis and can be used as independent predictors of HCC patient survival....

Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.

Venous thromboembolism (VTE) is a common disease with high heritability. However, only a small portion of the genetic variance of VTE can be explained by known genetic risk factors. Neutrophil extrace...

Mitochondrial DNA copy number and risk of papillary thyroid carcinoma.

Mitochondrial DNA (mtDNA) copy number is associated with tumor activity and carcinogenesis. This study was undertaken to investigate mtDNA copy number in papillary thyroid cancer (PTC) tissues and to ... DNA was extracted from 105 PTC tissues and 67 control thyroid tissues, and mtDNA copy number mtDNA oxidative damage were determined using qPCR techniques.... Overall, the relative mtDNA copy number was significantly higher in PTC patients (p < 0.001). The risk of developing PTC increased significantly across the tertiles of mtDNA copy number (p trend < 0.0... Our results indicated that the augmentation of mtDNA content plays a significant role during the initiation of thyroid cancer, and it might represent a potential biomarker for predicting the risk of P...

Copy number variations (CNVs) and karyotyping analysis in males with azoospermia and oligospermia.

Considering the essential roles that genetic factors play in azoospermia and oligospermia, this study aims to identify abnormal chromosomes using karyotyping and CNVs and elucidate the associated gene... A total of 1157 azoospermia and oligospermia patients were recruited, of whom, 769 and 674 underwent next-generation sequencing (NGS) to identify CNVs and routine G-band karyotyping, respectively.... First, 286 patients were co-analyzed using CNV sequencing (CNV-seq) and karyotyping. Of the 725 and 432 patients with azoospermia and oligospermia, 33.8% and 48.9% had abnormal karyotypes and CNVs, re... Sex chromosome and autosomal CNV loci, such as Xp22.31 and 2p24.3, as well as the associated genes, such as VCX and NACAP9, could be candidate spermatogenesis genes. The high-frequency abnormal karyot...

dbCNV: deleteriousness-based model to predict pathogenicity of copy number variations.

Copy number variation (CNV) is a type of structural variation, which is a gain or loss event with abnormal changes in copy number. Methods to predict the pathogenicity of CNVs are required to realize ... From single nucleotide polymorphism (SNP), gene and region dimensions, we collected 79 informative features that quantitatively describe the characteristics of CNV, such as CNV length, the number of p... The performance of the dbCNV suggest that functional deleteriousness-based model of CNV is a promising approach to support the classification prediction and to further understand the pathogenic mechan...